OR WAIT 15 SECS
Acquisition provides growth opportunities and increases synergies within the ProScan Family of Companies
ProScan Imaging, one an international radiology services group, has increased its majority ownership of WorldCare Clinical (WCC) LLC to 100 percent, aiming to position the organization for growth and increased synergies in technology, service offerings, expertise, and accredited educational programs to benefit their biopharmaceutical and device manufacturer customers.
“The acquisition allows us to more closely align WCC’s exceptional trial management and assessment accuracy and consistency testing methodology with ProScan’s world-wide medical image file exchange platform and its international teleradiology assets,” stated Michael O’Brien, President and COO of the ProScan Family of Companies. “The enhanced service delivery model will allow WCC’s customers to lower their trial costs, while flexibly accessing the most appropriate independent expert assessment team.”
“Our access to large groups of sub-specialty trained, practicing radiologists and clinicians at ProScan and Harvard teaching hospitals coupled with our rapid turnaround global teleradiology and telemedicine endpoint assessment committees (EACs), all uniquely position us to take advantage of the ever changing and more rigorous clinical trial requirements,” stated Dr. Richard Walovitch, President of WCC. “As the number of stakeholders involved in product life cycle management increases, WCC can provide continuity and efficiency of service, effective efficacy and safety evaluation, reporting, and continuing medical education, informing these stakeholders on the best path for their product from early clinical trial activity through commercialization.”